NCT00255840 - Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities | Biotech Hunter

Enrollment

812

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

HIV Infections

Interventions

BEHAVIORAL

Monitoring by an HIV-trained medical doctor

Participants will receive care from an HIV-trained medical doctor

BEHAVIORAL

Monitoring by an HIV-trained primary care nurse

Participants will receive care from an HIV-trained primary care nurse

DRUG

Efavirenz

600 mg tablet taken orally daily

DRUG

Lamivudine

150 mg tablet taken orally daily

DRUG

Lopinavir/Ritonavir

400 mg lopinavir/100mg ritonavir tablet taken orally twice daily

DRUG

Nevirapine

200 mg tablet taken orally for 14 days before taking a 200 mg tablet orally twice daily

DRUG

Stavudine

Tablet taken orally daily. Dosage depends on weight.

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

CIPRA SA

NETWORK